Finding hope by expanding the frontiers of therapy
We design ground-breaking therapies through precision-targeting of membrane receptors to bring hope to people living with autoimmune diseases
Latest News
First Peer-Reviewed Publication on FTX-101 is Now Online
Published in the open-access journal Biomedicine & Pharmacotherapy, this article highlights the dual mechanism of…
Two key experts joining us to accelerate the development of FTX-101
We’re pleased to welcome Dr. Nancy Messier and Dr. Thierry Abribat to our Board of…
Finding a new path in multiple sclerosis treatment
Find and its FTX-101 program gain visibility through a publication in the March 2025 issue…
Our investors
... share our passion for discovering and developing breakthrough science to bring hope to people’s lives
